CRCAM BRIE PIC2-CCI (CRBP2.PA) Stock Fundamental Analysis
Europe - EPA:CRBP2 - FR0010483768 - Common Stock
28 EUR
-0.42 (-1.48%)
CRBP2 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 96 industry peers in the Banks industry. Both the profitability and financial health of CRBP2 have multiple concerns. CRBP2 has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CRBP2 was profitable.
In the past year CRBP2 has reported a negative cash flow from operations.
Each year in the past 5 years CRBP2 has been profitable.
The reported operating cash flow has been mixed in the past 5 years: CRBP2 reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.53%, CRBP2 is in line with its industry, outperforming 42.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.86%, CRBP2 is doing worse than 73.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.53% | ||
| ROE | 3.86% | ||
| ROIC | N/A |
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 26.10%, CRBP2 is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
In the last couple of years the Profit Margin of CRBP2 has declined.
The Operating Margin and Gross Margin are not available for CRBP2 so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 26.1% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CRBP2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRBP2 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRBP2 has more shares outstanding
Compared to 1 year ago, CRBP2 has an improved debt to assets ratio.
2.2 Solvency
CRBP2 has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
CRBP2 has a Debt to Equity ratio of 0.20. This is amongst the best in the industry. CRBP2 outperforms 88.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC5.89%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
CRBP2 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
CRBP2 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.97% yearly.
CRBP2 shows a decrease in Revenue. In the last year, the revenue decreased by -1.48%.
CRBP2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.72% yearly.
EPS 1Y (TTM)7.82%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.31%
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.97, the valuation of CRBP2 can be described as very cheap.
Based on the Price/Earnings ratio, CRBP2 is valued cheaper than 86.46% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.45, CRBP2 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.97 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.53
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRBP2 has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.79, CRBP2 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, CRBP2 pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of CRBP2 has a limited annual growth rate of 1.20%.
Dividend Growth(5Y)1.2%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
The dividend of CRBP2 is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPA:CRBP2 (11/21/2025, 7:00:00 PM)
28
-0.42 (-1.48%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners3.86%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap448.28M
Revenue(TTM)837.21M
Net Income(TTM)218.51M
Analysts83.64
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.71
Dividend Growth(5Y)1.2%
DPN/A
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.97 | ||
| Fwd PE | N/A | ||
| P/S | 0.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.08 | ||
| P/tB | 0.08 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.02
EY14.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-27.7
FCFYN/A
OCF(TTM)-26.94
OCFYN/A
SpS52.29
BVpS353.77
TBVpS353.75
PEG (NY)N/A
PEG (5Y)3.53
Graham Number178.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.53% | ||
| ROE | 3.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 26.1% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 59.41% | ||
| Cap/Sales | 1.46% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC5.89%
ROIC/WACCN/A
Cap/Depr(3y)66.63%
Cap/Depr(5y)90.89%
Cap/Sales(3y)1.62%
Cap/Sales(5y)2.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.29%
OCF growth 3YN/A
OCF growth 5YN/A
CRCAM BRIE PIC2-CCI / CRBP2.PA FAQ
What is the ChartMill fundamental rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CRBP2.PA.
Can you provide the valuation status for CRCAM BRIE PIC2-CCI?
ChartMill assigns a valuation rating of 2 / 10 to CRCAM BRIE PIC2-CCI (CRBP2.PA). This can be considered as Overvalued.
What is the profitability of CRBP2 stock?
CRCAM BRIE PIC2-CCI (CRBP2.PA) has a profitability rating of 2 / 10.
What are the PE and PB ratios of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?
The Price/Earnings (PE) ratio for CRCAM BRIE PIC2-CCI (CRBP2.PA) is 6.97 and the Price/Book (PB) ratio is 0.08.
How financially healthy is CRCAM BRIE PIC2-CCI?
The financial health rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) is 2 / 10.